Laurent Debarbieux
3Patents
1h-index
5Co-inventors
33Inventor score
Filing activity: Apr 30, 2014 → Jun 21, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11040078B2 | Bacteriophage therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US11041147B2 | Bacteriophage strain capable of producing a lytic infection in the Escherichia coli ST131-025B:H4 clone | Emerging Cross-Sectional Technologies | 0 | Active |
| US11918613B2 | Bacteriophage therapy | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.